Pages that link to "Q35013988"
Jump to navigation
Jump to search
The following pages link to New therapeutics that antagonize endothelin: promises and frustrations (Q35013988):
Displaying 50 items.
- A mouse model for Costello syndrome reveals an Ang II-mediated hypertensive condition (Q24655745) (← links)
- It's all in your head: new insights into craniofacial development and deformation (Q24675572) (← links)
- Endothelin receptors as novel targets in tumor therapy (Q24797288) (← links)
- Activation mechanism of endothelin ETB receptor by endothelin-1 (Q27727996) (← links)
- The endothelin axis: emerging role in cancer (Q28206793) (← links)
- Ambrisentan, a non-peptide endothelin receptor antagonist (Q28260732) (← links)
- How were new medicines discovered? (Q29616641) (← links)
- Redox signaling, vascular function, and hypertension (Q33689229) (← links)
- Endothelin-1 inhibits prostate cancer growth in vivo through vasoconstriction of tumor-feeding arterioles (Q33873953) (← links)
- Anti-endothelin drugs in solid tumors (Q34021011) (← links)
- Synthesis, biology and clinical significance of pentacyclic triterpenes: a multi-target approach to prevention and treatment of metabolic and vascular diseases (Q34162283) (← links)
- Frequency of edema in patients with pulmonary arterial hypertension receiving ambrisentan (Q34205555) (← links)
- Macitentan (ACT-064992), a tissue-targeting endothelin receptor antagonist, enhances therapeutic efficacy of paclitaxel by modulating survival pathways in orthotopic models of metastatic human ovarian cancer. (Q34551567) (← links)
- Cranial skeletal biology. (Q35128228) (← links)
- Differential roles of endothelin-1 in angiotensin II-induced atherosclerosis and aortic aneurysms in apolipoprotein E-null mice (Q35168157) (← links)
- Chronic blockade of endothelin A and B receptors using macitentan in experimental renovascular disease (Q35207830) (← links)
- Physiology and pathology of endothelin-1 in renal mesangium. (Q35211305) (← links)
- New and emerging drug therapies for the management of acute heart failure. (Q35600523) (← links)
- Loss of Vav2 proto-oncogene causes tachycardia and cardiovascular disease in mice (Q35650885) (← links)
- Atrasentan: targeting the endothelin axis in prostate cancer (Q35964727) (← links)
- A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases (Q35978728) (← links)
- Vav3 proto-oncogene deficiency leads to sympathetic hyperactivity and cardiovascular dysfunction (Q36019359) (← links)
- Antibody-recruiting molecules: an emerging paradigm for engaging immune function in treating human disease (Q36108119) (← links)
- Atrasentan: a novel and rationally designed therapeutic alternative in the management of cancer (Q36185608) (← links)
- Treatment of pulmonary arterial hypertension with bosentan: from pathophysiology to clinical evidence. (Q36192759) (← links)
- The future of endothelin-receptor antagonism as treatment for systemic hypertension (Q36442583) (← links)
- The molecular origins of species-specific facial pattern (Q36510495) (← links)
- Regression of Renal Disease by Angiotensin II Antagonism Is Caused by Regeneration of Kidney Vasculature (Q36624639) (← links)
- Lactoferrin-endothelin-1 axis contributes to the development and invasiveness of triple-negative breast cancer phenotypes (Q36743192) (← links)
- Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis (Q36857782) (← links)
- Phase I safety study of escalating doses of atrasentan in adults with recurrent malignant glioma (Q37152004) (← links)
- Endothelin antagonists for diabetic and non-diabetic chronic kidney disease (Q37219055) (← links)
- Present and future drug treatments for chronic kidney diseases: evolving targets in renoprotection (Q37290939) (← links)
- Cardioprotective signaling by endothelin (Q37397982) (← links)
- Cyclooxygenase-2 Inhibition Limits Angiotensin II-Induced DNA Oxidation and Protein Nitration in Humans (Q37691994) (← links)
- The effects of acute and chronic exercise on the vasculature (Q37721496) (← links)
- Endothelin and hepatic wound healing (Q37855219) (← links)
- Novel effective drugs for diabetic kidney disease? or not? (Q38265818) (← links)
- Endothelin Receptor Antagonists: New Hope for Renal Protection? (Q38525983) (← links)
- Drug Treatment of Hypertension: Focus on Vascular Health. (Q38964342) (← links)
- The discovery of medicines for rare diseases (Q39152821) (← links)
- Prevention of renal ischemia-reperfusion injury by short hairpin RNA of endothelin A receptor in a rat model (Q39295218) (← links)
- Kinin B1receptor upregulation by angiotensin II and endothelin-1 in rat vascular smooth muscle cells: receptors and mechanisms (Q39656751) (← links)
- Increased MAPK activation and impaired insulin signaling in subcutaneous microvascular endothelial cells in type 2 diabetes: the role of endothelin-1. (Q41817585) (← links)
- Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension (Q42467860) (← links)
- Endothelin-1 suppresses long-chain fatty acid uptake and glucose uptake via distinct mechanisms in 3T3-L1 adipocytes (Q42473116) (← links)
- Concomitant antagonism of endothelial and vascular smooth muscle cell ETB receptors for endothelin induces hypertension in the hamster (Q42477928) (← links)
- Effect on blood pressure of combined inhibition of endothelin-converting enzyme and neutral endopeptidase with daglutril in patients with type 2 diabetes who have albuminuria: a randomised, crossover, double-blind, placebo-controlled trial (Q44392807) (← links)
- Endothelin receptor antagonists restore morphine analgesia in morphine tolerant rats (Q44512657) (← links)
- Associations of Endothelin Polymorphisms and Aneurysm Size at Time of Rupture (Q45055236) (← links)